Speaker Profile

Co-founder & CEO, Precia Group

Biography
Precia Group is a CRO co-founded by Donna Russell in 2020 to expand the number of women in research studies, especially in early phases. The company is focused on women’s reproductive health and pregnancy but will expand its service areas to include all aspects of women’s health across the lifespan. Prior to Precia Group, Russell worked in maternal health research, in the US as a Director of Research at Seattle Children’s Research Institute and globally, consulting with the Bill & Melinda Gates Foundation and other funders. She has extensive experience establishing biobanks to support pregnancy cohorts and research networks in the community-setting; and harmonizing collections across multiple networks to enable large-scale omics studies. She also serves on the board of a large community hospital affiliated with the University of Washington and has a deep understanding of how to successfully integrate research into the clinical setting to ensure high-quality, diverse, equitable studies.

Talk
A Community Based Research Model: Meeting Women Where They Are
Precia is focused on increasing the number of women in research studies by establishing the first-of-its-kind network of US community hospitals and clinics and engaging women as partners. This new model is enabling scientists and clinicians in academia and industry to access a significantly larger pool of women and a more racially, ethnically, socioeconomically, and geographically diverse cohort. This novel approach will further accelerate translational research and development of diagnostics, therapeutics and prevention strategies in women’s health across the lifespan.


 Session Abstract – PMWC 2022 Silicon Valley


Track Co-Chairs:
Aleksandar Rajkovic, UCSF

Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health:

  • Intro to Women's Health
    - Aleksandar Rajkovic, UCSF
  • US Regulatory/Personalized Medicine and Women's Health
    Session Chair: Kathryn G. Schubert, SWHR
    - Kaveeta Vasisht, FDA
  • Reproductive Health
    - Hakan Cakmak, UCSF
    - Laura Jelliffe-Pawlowski, UCSF
  • Pregnancy (PANEL)
    Session Chair: Yoel Sadovsky, University of Pittsburgh
    - Virginia D. Winn, Stanford
    - Ananth Karumanchi, Cedars-Sinai Medical Center
    - Mira Moufarrej, Stanford University
  • Carrier Screening: Perspective on the new ACMG Practice Resource
    - James D Goldberg, Women's Health Medical Affairs
  • Biological Sex Differences in Disease + Inclusion of Women in Clinical Research/Innovation
    - Rhonda Voskuhl, UCLA
  • Cardiovascular Health
    - Nisha Parikh, UCSF
    - Jennifer Ann Tremmel, Stanford
  • Bone Health/Osteoporosis & Menopause
    Session Chair: Risa Kagan, UCSF, Sutter Health
    - Danit Ariel, Stanford
    - Massimiliano (Max) de Zambotti, SRI International
  • Showcase
    - Carrie Haverty, Mirvie
    - Kevin P. Rosenblatt, NX Prenatal
    - Ripudaman Singh, ARCEDI Biotech
    - Claire Tomkins, Future Family
    - Donne Russell, Precia Group
    - Adam de la Zerda, Visby Medical, Inc.